Recombinant Human GCET2 protein (His tag N-Terminus)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human GCET2 protein (His tag N-Terminus) is a Human Full Length protein, in the 1 to 178 aa range, expressed in Escherichia coli, with >85%, suitable for SDS-PAGE, Mass Spec.
View Alternative Names
GAL, GCET2, GCSAM, Germinal center-associated signaling and motility protein, Germinal center B-cell-expressed transcript 2 protein, Germinal center-associated lymphoma protein, hGAL
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human GCET2 protein (His tag N-Terminus) (AB137147)
15% SDS-PAGE analysis of 3 µg ab137147.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein influences the immune response by contributing to the maturation and selection of B cells within germinal centers. Although not known to be a part of any larger complex its expression corresponds with stages critical to adaptive immunity. GCET2 supports the processes that ensure only high-affinity B cell receptors mature fostering a strong and specific immune defense.
Pathways
Researchers place GCET2 in connection with the germinal center reaction a significant pathway in adaptive immunity. This pathway involves interaction with proteins such as Bcl-6 which regulates the formation and maintenance of germinal centers. Another pathway is the somatic hypermutation process critical for antibody diversity where GCET2 may influence the changes in antibody affinity.
Specifications
Form
Liquid
Additional notes
ab137147 is purified using conventional chromatography techniques.
General info
Function
Involved in the negative regulation of lymphocyte motility. It mediates the migration-inhibitory effects of IL6. Serves as a positive regulator of the RhoA signaling pathway. Enhancement of RhoA activation results in inhibition of lymphocyte and lymphoma cell motility by activation of its downstream effector ROCK. Is a regulator of B-cell receptor signaling, that acts through SYK kinase activation.
Post-translational modifications
Phosphorylation on tyrosine residues can be induced by IL6. Phosphorylation is mediated by LYN.. Targeted by the ubiquitin E3 ligase subunit FBXO10 to mediate its ubiquitination and degradation.
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com